v1
Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in locoregionally advanced head & neck squamous cell carcinoma (HNSCC): Updated pathologic response and survival.
Identifier:nobleid.org/w1/20260515/BA5337F0
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/BA5337F0)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →